173 related articles for article (PubMed ID: 21866295)
1. Interaction of glycated human serum albumin with endothelial cells in a hemodynamic environment: structural and functional correlates.
Bala K; Gomes J; Gohil NK
Mol Biosyst; 2011 Nov; 7(11):3036-41. PubMed ID: 21866295
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms.
Grossin N; Wautier MP; Picot J; Stern DM; Wautier JL
Diabetes Metab; 2009 Nov; 35(5):410-7. PubMed ID: 19815443
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the molecular mechanisms underpinning biorecognition of early-glycated human serum albumin and receptor for advanced glycation end products.
Tramarin A; Naldi M; Degani G; Lupu L; Wiegand P; Mazzolari A; Altomare A; Aldini G; Popolo L; Vistoli G; Przybylski M; Bartolini M
Anal Bioanal Chem; 2020 Jul; 412(18):4245-4259. PubMed ID: 32367292
[TBL] [Abstract][Full Text] [Related]
4. Glycated serum albumin stimulates expression of endothelial cell specific molecule-1 in human umbilical vein endothelial cells: Implication in diabetes mediated endothelial dysfunction.
Nirala BK; Perumal V; Gohil NK
Diab Vasc Dis Res; 2015 Jul; 12(4):290-7. PubMed ID: 25963575
[TBL] [Abstract][Full Text] [Related]
5. Effect of garlic component s-allyl cysteine sulfoxide on glycated human serum albumin induced activation of endothelial cells: an in vitro study.
Nirala BK; Gohil NK
Eur Rev Med Pharmacol Sci; 2015; 19(11):2125-31. PubMed ID: 26125278
[TBL] [Abstract][Full Text] [Related]
6. Review: Glycation of human serum albumin.
Anguizola J; Matsuda R; Barnaby OS; Hoy KS; Wa C; DeBolt E; Koke M; Hage DS
Clin Chim Acta; 2013 Oct; 425():64-76. PubMed ID: 23891854
[TBL] [Abstract][Full Text] [Related]
7. Influence of Piracetam on Gliclazide-Glycated Human Serum Albumin Interaction. A Spectrofluorometric Study.
Szkudlarek A; Pożycka J; Maciążek-Jurczyk M
Molecules; 2018 Dec; 24(1):. PubMed ID: 30597970
[TBL] [Abstract][Full Text] [Related]
8. Interaction between glycated serum albumin and AGE-receptors depends on structural changes and the glycation reagent.
Indurthi VS; Leclerc E; Vetter SW
Arch Biochem Biophys; 2012 Dec; 528(2):185-96. PubMed ID: 23079546
[TBL] [Abstract][Full Text] [Related]
9. Effects of non-enzymatic glycation in human serum albumin. Spectroscopic analysis.
Szkudlarek A; Sułkowska A; Maciążek-Jurczyk M; Chudzik M; Równicka-Zubik J
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 152():645-53. PubMed ID: 25735846
[TBL] [Abstract][Full Text] [Related]
10. Amadori-modified glycated albumin predominantly induces E-selectin expression on human umbilical vein endothelial cells through NADPH oxidase activation.
Higai K; Shimamura A; Matsumoto K
Clin Chim Acta; 2006 May; 367(1-2):137-43. PubMed ID: 16455066
[TBL] [Abstract][Full Text] [Related]
11. Glycated albumin, a precursor of advanced glycation end-products, up-regulates NADPH oxidase and enhances oxidative stress in human endothelial cells: molecular correlate of diabetic vasculopathy.
Rodiño-Janeiro BK; González-Peteiro M; Ucieda-Somoza R; González-Juanatey JR; Alvarez E
Diabetes Metab Res Rev; 2010 Oct; 26(7):550-8. PubMed ID: 20818804
[TBL] [Abstract][Full Text] [Related]
12. Microglial cell death induced by glycated bovine serum albumin: nitric oxide involvement.
Khazaei MR; Habibi-Rezaei M; Karimzadeh F; Moosavi-Movahedi AA; Sarrafnejhad AA; Sabouni F; Bakhti M
J Biochem; 2008 Aug; 144(2):197-206. PubMed ID: 18463114
[TBL] [Abstract][Full Text] [Related]
13. Glycated Serum Albumin and AGE Receptors.
Vetter SW
Adv Clin Chem; 2015; 72():205-75. PubMed ID: 26471084
[TBL] [Abstract][Full Text] [Related]
14. Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway.
Guo ZJ; Niu HX; Hou FF; Zhang L; Fu N; Nagai R; Lu X; Chen BH; Shan YX; Tian JW; Nagaraj RH; Xie D; Zhang X
Antioxid Redox Signal; 2008 Oct; 10(10):1699-712. PubMed ID: 18576917
[TBL] [Abstract][Full Text] [Related]
15. Unveiling the molecular basis of inflamm-aging induced by advanced glycation end products (AGEs)-modified human serum albumin (AGE-HSA) in patients with different immune-mediated diseases.
Shen CY; Li KJ; Wu CH; Lu CH; Kuo YM; Hsieh SC; Yu CL
Clin Immunol; 2023 Jul; 252():109655. PubMed ID: 37257547
[TBL] [Abstract][Full Text] [Related]
16. Molecular Basis for the Involvement of Mammalian Serum Albumin in the AGE/RAGE Axis: A Comprehensive Computational Study.
Belinskaia DA; Jenkins RO; Goncharov NV
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542178
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products induce actin rearrangement and subsequent hyperpermeability of endothelial cells.
Guo XH; Huang QB; Chen B; Wang SY; Li Q; Zhu YJ; Hou FF; Fu N; Brunk UT; Zhao M
APMIS; 2006 Dec; 114(12):874-83. PubMed ID: 17207088
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end products on stored red blood cells increase endothelial reactive oxygen species generation through interaction with receptor for advanced glycation end products.
Mangalmurti NS; Chatterjee S; Cheng G; Andersen E; Mohammed A; Siegel DL; Schmidt AM; Albelda SM; Lee JS
Transfusion; 2010 Nov; 50(11):2353-61. PubMed ID: 20492604
[TBL] [Abstract][Full Text] [Related]
19. Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus.
Raghav A; Ahmad J; Alam K
PLoS One; 2017; 12(5):e0176970. PubMed ID: 28520799
[TBL] [Abstract][Full Text] [Related]
20. New insights into non-enzymatic glycation of human serum albumin biopolymer: A study to unveil its impaired structure and function.
Raghav A; Ahmad J; Alam K; Khan AU
Int J Biol Macromol; 2017 Aug; 101():84-99. PubMed ID: 28322944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
